Israeli Startup Founders Face a Financial Hurdle That Has Nothing to Do With Talent
A structural gap in how Israeli and American founders build their first budgets is emerging as a key obstacle to global competitiveness.
A structural gap in how Israeli and American founders build their first budgets is emerging as a key obstacle to global competitiveness.
Nutex Health reported improved Q2 2026 financials, with rising revenue and a return to net profitability as patient volumes grew.
Con Edison reported Q2 2026 earnings and raised its full-year guidance, signaling confidence in regulated utility growth.
Choice Hotels International posts Q2 2026 results, highlighting midscale segment strength and domestic leisure travel demand amid a cautious macro backdrop.
Recursion Pharmaceuticals reports Q2 results with expanding pipeline milestones, Nvidia partnership progress, and rising cash burn amid AI-driven drug discovery push.
Braveheart Bio prices its upsized IPO above expectations, raising over $200 million as investor appetite for biotech listings holds firm.
Israeli startup QuantiHealth raises $45m to expand its AI platform that simulates clinical trials, cutting drug development time and cost.
Athene Holding prices a $1 billion investment-grade senior notes offering, reinforcing the Apollo-backed insurer’s capital strategy amid robust fixed-income demand.
TAT Technologies delivers record Q2 2026 revenue and profit, driven by strong aerospace MRO demand and heat transfer segment growth.
Carriage Services reaffirms 2026 EPS midpoint guidance after reporting its second-quarter results, signaling confidence in its full-year outlook.